Milestone Pharmaceuticals Inc.
MIST
$1.34
$0.021.52%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -41.52M | -42.77M | -48.41M | -55.09M | -59.69M |
| Total Depreciation and Amortization | 646.00K | 611.00K | 610.00K | 608.00K | 598.00K |
| Total Amortization of Deferred Charges | 370.00K | 357.00K | 342.00K | 331.00K | 244.00K |
| Total Other Non-Cash Items | 8.00M | 8.42M | 9.94M | 11.14M | 11.18M |
| Change in Net Operating Assets | 3.66M | 1.58M | 578.00K | 1.56M | 1.24M |
| Cash from Operations | -28.85M | -31.80M | -36.94M | -41.45M | -46.42M |
| Capital Expenditure | -33.00K | -42.00K | -56.00K | -80.00K | -112.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 8.32M | 2.67M | -14.66M | -52.15M | 4.87M |
| Cash from Investing | 8.28M | 2.63M | -14.71M | -52.23M | 4.76M |
| Total Debt Issued | -- | 0.00 | 0.00 | 0.00 | 50.00M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 27.75M | 27.73M | 27.96M | 27.98M | 582.00K |
| Repurchase of Common Stock | -251.00K | -251.00K | -251.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 4.62M | 4.62M | 4.62M | 1.87M | -2.79M |
| Cash from Financing | 32.12M | 32.10M | 32.33M | 29.86M | 47.79M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 11.55M | 2.92M | -19.33M | -63.82M | 6.12M |